GUFIC BIOSCIENCES
Back to All Ratios
|
GUFIC BIOSCIENCES Last 5 Year Cash Profit Margin History
[Consolidated]
Mar2024 | |
---|---|
Cash Profit Margin (%) | 10.97 |
What is the latest Cash Profit Margin ratio of GUFIC BIOSCIENCES ?
Year | Cash Profit Margin |
---|---|
Mar2024 | 10.97 |
How is Cash Profit Margin of GUFIC BIOSCIENCES Trending?
Years | Cash Profit Margin | % Change | |
---|---|---|---|
Mar2024 | 10.97 | - |
Other Financial Ratios of GUFIC BIOSCIENCES
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT EV/CE M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare Cash Profit Margin ratio of peers of GUFIC BIOSCIENCES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
GUFIC BIOSCIENCES | ₹3,752.7 Cr | -1% | 9.8% | 9.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -4.1% | -2.1% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -2.8% | -5.9% | 29.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -4.1% | 7.3% | 14.3% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.7% | 0.1% | -2.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -5.7% | -6.1% | -11.6% | Stock Analytics |
GUFIC BIOSCIENCES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
GUFIC BIOSCIENCES | -1% |
9.8% |
9.6% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses